Weed (BUDZ) Gains from Investment Securities (2020 - 2025)

Weed (BUDZ) recorded quarterly Gains from Investment Securities of $33.0 in Q3 2025, down 91.73% quarter-over-quarter from $399.0 in Q2 2024.

Weed (BUDZ) Gains from Investment Securities (2020 - 2025) Analysis & Trends

Weed's Gains from Investment Securities history runs 4 years deep, the most recent figure standing at $33.0 for Q3 2025.

In Q3 2025, Gains from Investment Securities changed N/A year-over-year to $33.0; the TTM figure through Mar 2026 stood at $33.0 (down 91.73% YoY), while the FY2025 annual figure was $6.0 million, changed 0.0% from the prior year.
Gains from Investment Securities was $33.0 for Q3 2025 at Weed, down from $399.0 in the prior quarter.
In the past five years, Gains from Investment Securities ranged from a high of $980.0 in Q4 2023 to a low of $33.0 in Q3 2025.
Historically, Gains from Investment Securities has averaged $470.67 across 3 years, with a median of $399.0 in 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	38.77 Bn	35.04 Bn	1.97 Bn
2	Zoetis	34.11 Bn	32.16 Bn	1.62 Bn
3	United Therapeutics	23.68 Bn	21.53 Bn	648.10 Mn
4	Aurora Cannabis	16.48 Bn	16.40 Bn	33.43 Mn
5	Neurocrine Biosciences	16.19 Bn	14.88 Bn	800.70 Mn
6	Elanco Animal Health	11.44 Bn	11.01 Bn	785.00 Mn
7	Alkermes	7.28 Bn	6.77 Bn	-116.06 Mn
8	Lantheus Holdings	6.48 Bn	5.98 Bn	230.92 Mn
9	Hims & Hers Health	6.35 Bn	5.60 Bn	396.79 Mn
10	Weed	-	-	-

Download Data